Prism Medico

Market Cap: Micro Cap
Industry: Non Banking Financial Company (NBFC)
ISIN: INE730E01016
NSEID:
BSEID: 512217

INR

19.80

-0.27 (-1.35%)

BSENSE

Dec 19

BSE+NSE Vol: 1.78 k

{
  "main_header": {
    "sid": 701766,
    "name": "Prism Medico",
    "stock_name": "Prism Medico",
    "full_name": "Prism Medico & Pharmacy Ltd",
    "name_url": "stocks-analysis/prism-medico",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "19.80",
    "chg": -0.27,
    "chgp": "-1.35%",
    "dir": -1,
    "prev_price": "20.07",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512217,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE730E01016",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "1.78 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prism-medico-701766-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Prism Medico falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-prism-medico-fallingrising-3763056",
        "imagepath": "",
        "date": "2025-12-19 01:48:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Gains Outpace Market and Sector</strong></p>\n<p>Prism Medico’s recent price action stands out sharply against the backdrop of the broader market. Over the past week, the stock surged by 16.08%, while the Sensex declined marginally by 0.40%. This divergence highlights a strong investor interest in the company’s shares in the near term. Even over the last month, Prism Medico posted a modest gain of 2.19%, outperforming the Sensex’s slight fall of 0.23%. Such short-term gains are further underscored by the stock’s consecutive two-day rise, delivering an 8.49% return during this period.</p>\n<p>These gains are supported by technical indicators, with the stock trading above all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical strengt..."
      },
      {
        "title": "Prism Medico’s Evaluation Revised Amidst Weak Fundamentals and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3755251",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedico_mojoScore_3755251.png",
        "date": "2025-12-10 10:10:07",
        "description": "Prism Medico, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market assessment reflecting challenges in its financial health and stock performance. Recent analytical changes highlight concerns over the company’s operational results and market returns, signalling a cautious outlook for investors."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3746826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3746826.png",
        "date": "2025-12-04 13:25:40",
        "description": "Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum amid a series of consecutive losses."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3744351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3744351.png",
        "date": "2025-12-03 13:45:24",
        "description": "Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals heightened market caution surrounding the company’s near-term prospects."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3737823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3737823.png",
        "date": "2025-12-01 09:50:25",
        "description": "Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.96% today and exhibiting no buying interest. This distress selling comes amid a series of consecutive losses, signalling heightened investor caution in the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728113",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_only_sellers_3728113.png",
        "date": "2025-11-25 09:40:58",
        "description": "Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling has resulted in a continuation of losses, reflecting a challenging phase for the company within the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3725370",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_only_sellers_3725370.png",
        "date": "2025-11-24 11:30:41",
        "description": "Prism Medico & Pharmacy Ltd is experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment for this Non Banking Financial Company (NBFC)."
      },
      {
        "title": "Is Prism Medico overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prism-medico-overvalued-or-undervalued-3713567",
        "imagepath": "",
        "date": "2025-11-19 08:08:21",
        "description": "As of 18 November 2025, the valuation grade for Prism Medico has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. The key ratios include a PE ratio of 19.52, an EV to EBITDA of 11.84, and a Price to Book Value of 0.79. \n\nIn comparison to its peers, Prism Medico's valuation is significantly lower than that of Max Healthcare, which has a PE ratio of 77.03, and Apollo Hospitals, with a PE ratio of 63.51. Despite the fair valuation, Prism Medico has underperformed the Sensex over the past year, with a stock return of -24.32% compared to the Sensex's return of 9.48%...."
      },
      {
        "title": "Prism Medico & Pharmacy Q2 2025 Financial Trend Shows Flat Performance Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-q2-2025-financial-performance-flatlines-amid-margin-pressures-3714073",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_fintrenddot_3714073.png",
        "date": "2025-11-19 08:00:30",
        "description": "Prism Medico & Pharmacy, a player in the Non Banking Financial Company (NBFC) sector, reported a flat financial trend for the quarter ending September 2025, marking a shift from its previous positive trajectory. The company’s financial trend score declined to -3 from 7 over the past three months, reflecting a period of subdued operational performance despite a modest rise in profit after tax (PAT) over the last six months."
      }
    ],
    "total": 158,
    "sid": "701766",
    "stock_news_url": "https://www.marketsmojo.com/news/prism-medico-pharmacy-701766"
  },
  "announcements": [
    {
      "caption": "Revised Outcome Of The Board Meeting Held On 14Th November 2025.",
      "datetime": "21-Nov-2025",
      "details": "Dear Sir/Madam With reference to the email dated 21st November 2025 please find attached revised outcome of the Board meeting held on 14th November 2025. You are requested to take the same on record and oblige. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 14th November 2025) which commenced at 03:30 P.M. and concluded at 06:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September 2025 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting.",
      "datetime": "06-Nov-2025",
      "details": "Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter and half year ended 30th September 2025 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Consider and discuss any other routine matter or business of the company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Prism Medico falling/rising?

2025-12-19 01:48:58

Short-Term Gains Outpace Market and Sector

Prism Medico’s recent price action stands out sharply against the backdrop of the broader market. Over the past week, the stock surged by 16.08%, while the Sensex declined marginally by 0.40%. This divergence highlights a strong investor interest in the company’s shares in the near term. Even over the last month, Prism Medico posted a modest gain of 2.19%, outperforming the Sensex’s slight fall of 0.23%. Such short-term gains are further underscored by the stock’s consecutive two-day rise, delivering an 8.49% return during this period.

These gains are supported by technical indicators, with the stock trading above all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical strengt...

Prism Medico’s Evaluation Revised Amidst Weak Fundamentals and Market Underperformance

2025-12-10 10:10:07

Prism Medico, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market assessment reflecting challenges in its financial health and stock performance. Recent analytical changes highlight concerns over the company’s operational results and market returns, signalling a cautious outlook for investors.

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 13:25:40

Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum amid a series of consecutive losses.

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 13:45:24

Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals heightened market caution surrounding the company’s near-term prospects.

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-01 09:50:25

Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.96% today and exhibiting no buying interest. This distress selling comes amid a series of consecutive losses, signalling heightened investor caution in the Non Banking Financial Company (NBFC) sector.

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 09:40:58

Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling has resulted in a continuation of losses, reflecting a challenging phase for the company within the Non Banking Financial Company (NBFC) sector.

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 11:30:41

Prism Medico & Pharmacy Ltd is experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment for this Non Banking Financial Company (NBFC).

Is Prism Medico overvalued or undervalued?

2025-11-19 08:08:21

As of 18 November 2025, the valuation grade for Prism Medico has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. The key ratios include a PE ratio of 19.52, an EV to EBITDA of 11.84, and a Price to Book Value of 0.79. In comparison to its peers, Prism Medico's valuation is significantly lower than that of Max Healthcare, which has a PE ratio of 77.03, and Apollo Hospitals, with a PE ratio of 63.51. Despite the fair valuation, Prism Medico has underperformed the Sensex over the past year, with a stock return of -24.32% compared to the Sensex's return of 9.48%....

Prism Medico & Pharmacy Q2 2025 Financial Trend Shows Flat Performance Amid Sector Challenges

2025-11-19 08:00:30

Prism Medico & Pharmacy, a player in the Non Banking Financial Company (NBFC) sector, reported a flat financial trend for the quarter ending September 2025, marking a shift from its previous positive trajectory. The company’s financial trend score declined to -3 from 7 over the past three months, reflecting a period of subdued operational performance despite a modest rise in profit after tax (PAT) over the last six months.

View All News

Announcement

Revised Outcome Of The Board Meeting Held On 14Th November 2025.

21-Nov-2025 | Source : BSE

Dear Sir/Madam With reference to the email dated 21st November 2025 please find attached revised outcome of the Board meeting held on 14th November 2025. You are requested to take the same on record and oblige. Thanking You.

Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

14-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 14th November 2025) which commenced at 03:30 P.M. and concluded at 06:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September 2025 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You.

Board Meeting Intimation for Intimation Of Board Meeting.

06-Nov-2025 | Source : BSE

Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter and half year ended 30th September 2025 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Consider and discuss any other routine matter or business of the company.